RxDoctor Payments DataLook up a doctor →

Daria Lee, MD

Pulmonary Disease · Fort Wayne, INNPI 1235199613

Payments from drug & device makers

$79,658in general payments, 2019–2025

Across 392 payments — averaging $203.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mylan Specialty L.p.$54K
  • AstraZeneca$10K
  • Sunovion Pharmaceuticals Inc.$6K
  • GSK$3K
  • Astrazeneca UK Limited$2K
  • United Therapeutics Corporation$586
  • plus $5K from 33 others
$32in research payments, 2019–2025

Across 1 payment — averaging $31.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$32

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$79,658 in reported general payments places this provider in the 90th percentile of 258 pulmonary disease providers in Indiana.

See all pulmonary disease providers in Indiana

Medicare billing

Part B allowed, 2024
$64,587
Medicare patients
331
Services billed
1,011

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →